44 Wealth Management LLC trimmed its stake in shares of The Clorox Company (NYSE:CLX – Free Report) by 9.9% in the 4th quarter, HoldingsChannel reports. The firm owned 7,551 shares of the company’s stock after selling 827 shares during the period. 44 Wealth Management LLC’s holdings in Clorox were worth $1,226,000 as of its most recent SEC filing.
A number of other large investors have also recently made changes to their positions in CLX. State Street Corp boosted its position in shares of Clorox by 3.1% during the 3rd quarter. State Street Corp now owns 8,182,109 shares of the company’s stock worth $1,332,947,000 after acquiring an additional 245,525 shares in the last quarter. Mizuho Securities USA LLC lifted its stake in shares of Clorox by 46,877.8% in the 3rd quarter. Mizuho Securities USA LLC now owns 4,500,000 shares of the company’s stock worth $733,095,000 after acquiring an additional 4,490,421 shares during the period. Geode Capital Management LLC boosted its holdings in Clorox by 1.1% in the 3rd quarter. Geode Capital Management LLC now owns 3,028,333 shares of the company’s stock valued at $491,713,000 after purchasing an additional 33,970 shares in the last quarter. Stifel Financial Corp lifted its holdings in Clorox by 1.7% in the third quarter. Stifel Financial Corp now owns 2,334,826 shares of the company’s stock valued at $380,370,000 after acquiring an additional 37,967 shares during the period. Finally, Van ECK Associates Corp boosted its holdings in Clorox by 2.2% during the third quarter. Van ECK Associates Corp now owns 1,492,717 shares of the company’s stock worth $237,372,000 after buying an additional 31,510 shares in the last quarter. 78.53% of the stock is currently owned by hedge funds and other institutional investors.
Clorox Stock Up 2.8 %
NYSE CLX opened at $157.41 on Friday. The stock’s 50 day simple moving average is $157.87 and its 200 day simple moving average is $159.63. The company has a debt-to-equity ratio of 20.52, a current ratio of 0.94 and a quick ratio of 0.60. The Clorox Company has a one year low of $127.60 and a one year high of $171.37. The firm has a market cap of $19.39 billion, a PE ratio of 43.01, a price-to-earnings-growth ratio of 2.58 and a beta of 0.42.
Wall Street Analyst Weigh In
CLX has been the topic of a number of recent research reports. Barclays upped their target price on Clorox from $130.00 to $140.00 and gave the company an “underweight” rating in a research note on Wednesday, February 5th. TD Cowen upgraded shares of Clorox from a “sell” rating to a “hold” rating and lifted their price target for the company from $155.00 to $170.00 in a report on Wednesday, November 6th. DA Davidson dropped their target price on shares of Clorox from $171.00 to $169.00 and set a “neutral” rating for the company in a research report on Wednesday, February 5th. Royal Bank of Canada restated a “sector perform” rating and set a $150.00 price objective on shares of Clorox in a research note on Thursday, January 30th. Finally, Wells Fargo & Company lifted their price target on shares of Clorox from $157.00 to $161.00 and gave the stock an “equal weight” rating in a research note on Tuesday, February 4th. Four research analysts have rated the stock with a sell rating, eleven have given a hold rating and one has assigned a buy rating to the stock. According to MarketBeat.com, the company has an average rating of “Hold” and a consensus target price of $158.21.
View Our Latest Analysis on Clorox
Clorox Profile
The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.
Read More
- Five stocks we like better than Clorox
- Are These Liquid Natural Gas Stocks Ready For An Upside Bounce?
- MarketBeat Week in Review – 02/17 – 02/21
- 3 Stocks to Protect Your Portfolio from the Coronavirus Contagion
- SolarEdge: A Surprising Bright Spot in a Troubled Solar Industry?
- What Does Downgrade Mean in Investing?
- 3 Stocks Poised to Thrive as NVIDIA Dominates the AI Boom
Want to see what other hedge funds are holding CLX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for The Clorox Company (NYSE:CLX – Free Report).
Receive News & Ratings for Clorox Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clorox and related companies with MarketBeat.com's FREE daily email newsletter.